These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38551680)

  • 21. Diagnostic challenges in patients with temporal lobe seizures and features of autoimmune limbic encephalitis.
    Ismail FS; Spatola M; Woermann FG; Popkirov S; Jungilligens J; Bien CG; Wellmer J; Schlegel U
    Eur J Neurol; 2022 May; 29(5):1303-1310. PubMed ID: 34288284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody prevalence and immunotherapy response in Chinese patients with epilepsy and encephalopathy scores for patients with different neuronal surface antibodies.
    Jia Y; Wang HF; Zhang MY; Wang YP
    Chin Med J (Engl); 2021 Dec; 134(24):2985-2991. PubMed ID: 34882621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
    Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
    Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal B-cell activation in LGI1 antibody encephalitis.
    Lehmann-Horn K; Irani SR; Wang S; Palanichamy A; Jahn S; Greenfield AL; Dandekar R; Lepennetier G; Michael S; Gelfand JM; Geschwind MD; Wilson MR; Zamvil SS; von Büdingen HC
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32029531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature.
    Kong DL
    World J Clin Cases; 2023 Jan; 11(2):408-416. PubMed ID: 36686352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF Findings in Chinese Patients with NMDAR, LGI1 and GABABR Antibody-Associated Encephalitis.
    Qiao S; Li H; Cui C; Zhang C; Wang A; Jiang W; Zhang S
    J Inflamm Res; 2024; 17():1765-1776. PubMed ID: 38523682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
    Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
    Li G; Liu X; Wang M; Yu T; Ren J; Wang Q
    Acta Neurol Scand; 2022 Aug; 146(2):137-143. PubMed ID: 35373330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    Chen L; Su T; Liu Y
    BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis.
    Campetella L; Farina A; Villagrán-García M; Villard M; Benaiteau M; Timestit N; Vogrig A; Picard G; Rogemond V; Psimaras D; Rafiq M; Chanson E; Marchal C; Goncalves D; Joubert B; Honnorat J; Muñiz-Castrillo S
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200228. PubMed ID: 38603771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features.
    Qiao S; Sun Q; Li H; Yin J; Wang A; Zhang S
    Clin Epigenetics; 2023 Aug; 15(1):139. PubMed ID: 37644514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric Manifestation of Anti-LGI1 Encephalitis.
    Endres D; Prüss H; Dressing A; Schneider J; Feige B; Schweizer T; Venhoff N; Nickel K; Meixensberger S; Matysik M; Maier SJ; Domschke K; Urbach H; Meyer PT; Tebartz van Elst L
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32560097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
    Müller-Jensen L; Zierold S; Versluis JM; Boehmerle W; Huehnchen P; Endres M; Mohr R; Compter A; Blank CU; Hagenacker T; Meier F; Reinhardt L; Gesierich A; Salzmann M; Hassel JC; Ugurel S; Zimmer L; Banks P; Spain L; Soon JA; Enokida T; Tahara M; Kähler KC; Seggewiss-Bernhardt R; Harvey C; Long GV; Schöberl F; von Baumgarten L; Hundsberger T; Schlaak M; French LE; Knauss S; Heinzerling LM
    Eur J Cancer; 2022 Nov; 175():224-235. PubMed ID: 36155116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
    Wang S; Wang J; Li B; Hu N; Jin Y; Han S; Shang X
    Front Immunol; 2023; 14():1191823. PubMed ID: 37304289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands.
    Xue H; Guo X; Jiang Y; Qin L; Wang X; Xu J; Zuo S; Liu Q; Li W
    Front Neurol; 2023; 14():1281276. PubMed ID: 38249729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.
    Ariño H; Armangué T; Petit-Pedrol M; Sabater L; Martinez-Hernandez E; Hara M; Lancaster E; Saiz A; Dalmau J; Graus F
    Neurology; 2016 Aug; 87(8):759-65. PubMed ID: 27466467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune encephalitis related to LGI1 antibodies with negative MRI study: Description of two cases.
    Lian X; Zheng K; Chen W; Li D; Xue F; Wang G
    Med Clin (Barc); 2024 Jan; 162(1):35-38. PubMed ID: 37517931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.